Impact of history of vascular disease on lipoprotein(a) associations with cardiovascular outcomes: a Mendelian randomisation study in 283,658 UK Biobank participants
1 September 2019 (10:05 - 10:55)
Organised by:
Abstract
About the speaker
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
6 More presentations in this session
Doctor E. Martinez Rey-Ranal (Elche, ES)
Doctor K. Svendsen (Oslo, NO)
Cost-effectiveness of evolocumab in patients with high atherosclerotic cardiovascular risk in Sweden
Doctor E. Hagstrom (Uppsala, SE)
Professor G. Schwartz (Aurora, US)
Access the full session
The Event
ESC Congress 2019
1 September 2019
10:05 CET
